α-Synuclein impairs macroautophagy: implications for Parkinson’s disease

نویسندگان

  • Ashley R. Winslow
  • Chien-Wen Chen
  • Silvia Corrochano
  • Abraham Acevedo-Arozena
  • David E. Gordon
  • Andrew A. Peden
  • Maike Lichtenberg
  • Fiona M. Menzies
  • Brinda Ravikumar
  • Sara Imarisio
  • Steve Brown
  • Cahir J. O’Kane
  • David C. Rubinsztein
چکیده

Parkinson's disease (PD) is characterized pathologically by intraneuronal inclusions called Lewy bodies, largely comprised of α-synuclein. Multiplication of the α-synuclein gene locus increases α-synuclein expression and causes PD. Thus, overexpression of wild-type α-synuclein is toxic. In this study, we demonstrate that α-synuclein overexpression impairs macroautophagy in mammalian cells and in transgenic mice. Our data show that α-synuclein compromises autophagy via Rab1a inhibition and Rab1a overexpression rescues the autophagy defect caused by α-synuclein. Inhibition of autophagy by α-synuclein overexpression or Rab1a knockdown causes mislocalization of the autophagy protein, Atg9, and decreases omegasome formation. Rab1a, α-synuclein, and Atg9 all regulate formation of the omegasome, which marks autophagosome precursors.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

α-Synuclein levels modulate Huntington's disease in mice

α-Synuclein and mutant huntingtin are the major constituents of the intracellular aggregates that characterize the pathology of Parkinson's disease (PD) and Huntington's disease (HD), respectively. α-Synuclein is likely to be a major contributor to PD, since overexpression of this protein resulting from genetic triplication is sufficient to cause human forms of PD. We have previously demonstrat...

متن کامل

TiO2 Nanoparticles as Potential Promoting Agents of Fibrillation of α-Synuclein, a Parkinson’s Disease-Related Protein

Background: In recent years, nanomaterials have been widely used in large quantities which make people bemore frequently exposed to the chemically synthesized nanoparticles (NPs). When NPs are introduced intoan organism, they may interact with a variety of cellular components with yet largely unknown pathologicalconsequences.Objective: I...

متن کامل

Oxidative Stress, α-Synuclein, and Apoptosis in Parkinson’s Disease

Parkinson’s Disease is a neurodegenerative disease that is pathologically characterized by abnormal α-synuclein protein aggregation, dopamine depletion in nigrostriatal neurons, and the subsequent death of these neurons. Oxidative stress has been widely implicated as a cause for neurodegenerative diseases, especially Parkinson’s Disease (PD). The mechanisms by which oxidative stress occurs in P...

متن کامل

Macroautophagy and the proteasome are differently involved in the degradation of alpha-synuclein wild type and mutated A30P in an in vitro inducible model (PC12/TetOn)

Many data suggest that alpha synuclein (α-syn) aggregation is involved in Parkinson's disease (PD) neurotoxicity and is accelerated by the pathogenetic point mutation A30P. The triplication of α-syn gene has been linked to early-onset familial PD, suggesting that the cellular dosage of α-syn is an important modulator of its toxicity. To verify this point, we developed an inducible model of α-sy...

متن کامل

Evaluating α-Synuclein’s Interaction with Cellular Phospholipids and Potential Toxicity in Yeast Models for Parkinson’s Disease

Parkinson’s disease is a progressive neurodegenerative disease caused by the death of midbrain dopaminergic neurons. The misfolding and aggregation of α-synuclein plays a ruinous role in this disease, but how the protein becomes toxic is unclear. Using yeasts as model organisms for studying α-synuclein properties, our study explores the hypothesis that α-synuclein toxicity depends on plasma mem...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 190  شماره 

صفحات  -

تاریخ انتشار 2010